Jeyakumar, Niroshan
Lerch, Magdalena
Dale, Russell C.
Ramanathan, Sudarshini http://orcid.org/0000-0002-0294-9768
Article History
Received: 19 January 2024
Revised: 4 April 2024
Accepted: 19 April 2024
First Online: 23 May 2024
Competing interests
: NJ and ML have no financial disclosures to report. RD has received research funding from the Star Scientific Foundation, The Trish Multiple Sclerosis Research Foundation, Multiple Sclerosis Research Australia, the Petre Foundation and the NHMRC (Australia; Investigator Grant). He has also received honoraria from Biogen Idec as an invited speaker, and is on the IDMC for a Roche RCT in paediatric MS. He is on the medical advisory board (non-remunerated position) of The MOG Project. SR has received research funding from the National Health and Medical Research Council (NHMRC, Australia), the Petre Foundation, the Brain Foundation, the Royal Australasian College of Physicians, and the University of Sydney. She is supported by an NHMRC Investigator Grant (GNT2008339). She serves as a consultant on an advisory board for UCB and Limbic Neurology, and has been an invited speaker for educational/research sessions coordinated by Biogen, Alexion, Novartis, Excemed and Limbic Neurology. She is on the medical advisory boards (non-remunerated positions) of The MOG Project and the Sumaira Foundation.